AFP and hepatocellular carcinoma: As a novel potential diagnostic tool for HCC, even though the performance of gut microbiome is currently limited in scale and lacking extensive sample validation, the predictive model using gut microbiome together with AFP demonstrated better accuracy (AUROC: 0.9811 vs. 0.8505) (Yang et al. 2023), suggesting its potential complementary effect to the serum testable markers.